Mednet Logo
HomeEndocrinologyQuestion

How do you transition to an anabolic agent in a patient who develops an atypical fracture while on denosumab?

5
1 Answers
Mednet Member
Mednet Member
Rheumatology · UC Davis

It is not usual to suffer an atypical fracture of the femur from denosumab, however, they do occur. It is useful to start an anabolic agent, either abaloparatide or teriparatide for both augment fracture healing and to treat the osteoporosis. Both abaloparatide and teriparatide stimulate bone format...

Register or Sign In to see full answer

How do you transition to an anabolic agent in a patient who develops an atypical fracture while on denosumab? | Mednet